Cite
MLA Citation
L Malorni et al.. “Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial.” Annals of oncology, vol. 29, 2018, pp. 1748–1754. http://access.bl.uk/ark:/81055/vdc_100095479595.0x00003b